javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.6056524369.4343
Domestic EquitiesDivi's Laboratories Ltd.7.5569100836.7223
Domestic EquitiesApollo Hospitals Enterprise Ltd.6.633672175.9010
Domestic EquitiesTorrent Pharmaceuticals Ltd.6.5104131305.7914
Domestic EquitiesNeuland Laboratories Ltd.5.492128594.8855
Domestic EquitiesNavin Fluorine International Ltd.5.382267164.7878
Domestic EquitiesAurobindo Pharma Ltd.4.9789310504.4290
Domestic EquitiesFortis Healthcare Ltd.4.4913430323.9953
Domestic EquitiesGland Pharma Ltd.3.5520140433.1597
Domestic EquitiesZydus Lifesciences Ltd.3.1499260002.8020
Domestic EquitiesOnesource Specialty Pharma Ltd.3.0785150092.7385
Domestic EquitiesAster DM Healthcare Ltd.3.0704375002.7313
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.0673119942.7285
Domestic EquitiesBiocon Ltd.3.0598635002.7219
Domestic EquitiesGlobal Health Ltd.2.9743222522.6458
Domestic EquitiesMetropolis Healthcare Ltd.2.9532473042.6270
Domestic EquitiesArtemis Medicare Services Ltd.2.8741935292.5567
Domestic EquitiesIPCA Laboratories Ltd.2.8454166042.5311
Domestic EquitiesMankind Pharma Ltd.2.290685772.0376
Domestic EquitiesAcutaas Chemicals Ltd.2.217162961.9722
Domestic EquitiesAnthem Biosciences Ltd.2.1642253331.9252
Domestic EquitiesDr Agarwal's Health Care Ltd.2.1538395761.9159
Domestic EquitiesMax Healthcare Institute Ltd.1.8200167751.6190
Total 92.9216 82.6590
Cash & Cash Equivalents and Net AssetsTreps7.2913 6.4860
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.2129 -0.1894
Total 7.0784 6.2966
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.